SOURCE: Anoto Group

June 16, 2008 08:00 ET

Anoto Customers Present Digital Pen and Paper Healthcare Applications at the 44th Annual DIA Meeting

Anoto Partners to Give Hands-On Demonstration at Numerous Booths During DIA

BOSTON, MA--(Marketwire - June 16, 2008) -

"How the Emerging Technology of Digital Pen and Paper is
Bringing New Ideas and Power to Electronic Data Capture
in Clinical Studies and Healthcare Projects," presented
by Massimo Raineri, Head of Systems Development for Actelion
Pharmaceuticals, at the 44th Annual Meeting of the Drug Information
Association (DIA) on Wednesday, June 25th from 1:30pm until 3:00pm. The
session takes place within the Clinical Data Management track and features
three international speakers who will discuss their own real-life
experiences implementing Digital Pen and Paper technology.  This session

--  Describe the impact of Digital Pen and Paper on successful data
    management and workflow;
--  Present how to efficiently embrace the usage of Digital Pen and Paper
    as an easy, non-invasive interface to capture patient's data in digital
--  Identify opportunities and challenges in new electronic data capture
    techniques; and
--  Discuss the pros and cons of different methods of electronic data

The DIA Annual Meeting, which is being held at the Boston Convention Center
in Massachusetts, expects to draw 8500 attendees this year.

Massimo Raineri, PhD
Head of System Development -- Biometry, Actelion Pharmaceuticals (Italy)
Session Chairperson

Brigitte Picandet, FACP,
Project Director, Servier (France)
Topic: Use of Digital Pen in International Clinical Trials: Experience
and Perspectives

Siobhan Sharkey, MBA
Managing Director, Health Management Strategies, Inc. (United States)
Topic: On-time Quality Improvement in Long Term Care: Health IT and
Redesign Improve Clinical Outcomes (for Pressure Ulcer Prevention and

Petter Ericsson
Chief Science Officer, Anoto Group AB (Sweden)
Topic: Pros and Cons with Digital Pen and Paper in Healthcare Data Capture

About the Session:
Digital pen and paper technology is a smart, easy to use, and non-invasive
interface which can capture patient data and transform it into digital
format. It is now a reality in the collection of clinical data, and fits
perfectly with the electronic data capture trend, adding the benefits of an
easy and natural approach from the end-user perspective. DPP has been used
by many pharmaceutical companies and CROs to collect case report form data
in phases 2, 3, and 4 of multinational clinical trials, as well as to
streamline workflow in long-term care health projects.

DIA Conference and Exhibition:
June 25, 1:30PM - 3:00PM
Track: Clinical Data Management (CDM)

Boston Convention and Exhibition Center
415 Summer Street
Boston, Massachusetts 02210

Booth Demonstrations by Anoto Partners:
Arco at the eclinics Solutions Booth 123
Kayentis at Booth 1939
Mi-Co at the Anoto Booth 2025

Anoto Group AB

Anoto Group is the company behind and world leading in the unique technology for digital pen and paper, which enables fast and reliable transmission of handwritten text into a digital format. Anoto operates through a global partner network that focuses on user-friendly forms solutions for efficient capture, transmission and storage of data within different business segments, e.g. healthcare, bank and finance, transport and logistics and education. The Anoto Group has around 110 employees, offices in Lund (head office), Boston and Tokyo. Among the major shareholders are Norden Technology A/S, Robur and SEB. The Anoto share is traded on the Small Cap list of the OMX Nordic Exchange in Stockholm under the ticker ANOT. For more information:

Contact Information

  • Contact:

    Ripple Effect Communications
    Valerie Harding (Media)
    Email Contact
    (617) 536-8887